Search

Your search keyword '"MEDICAL marijuana"' showing total 18 results
18 results on '"MEDICAL marijuana"'

2. Between Stoned and a Hard Place? Navigating Cannabis Medicolegal Issues.

Author

Hicks, Chandler, Lapchenko, Maria, Saxton, Adrienne, and West, Sara

Subjects
*MEDICAL marijuana laws, *ACQUISITION of property, *AUTOMOBILE driving, *CANNABIS (Genus), *DECISION making, *EDUCATION, *EMPLOYMENT, *FIREARMS, *LABOR discipline, *MALPRACTICE, *MANAGEMENT, *MEDICAL prescriptions, *PHYSICIANS, *PROFESSIONS, *TRAVEL, *MEDICAL marijuana, *CONTINUING education units, *THERAPEUTICS
Abstract

The article advises clinicians about the medicolegal issues surrounding medical cannabis (MC) in the U.S. An overview of the history of MC is provided. Topics mentioned include the areas of variation in MC legislations in U.S. states, the restriction on gun ownership for users of medical marijuana, and the legal risks facing physicians for recommending marijuana for treating a condition including malpractice and criminal charges.

Published
2020

4. Cannabidiol use in children: There is little evidence of efficacy and safety of thecannabidiol(CBD)productsfloodingthemarket when it comes to use in children. Here's what pediatricians should know and what to tell parents.

Author

SCHUMAN, ANDREW J.

Subjects
SEIZURES (Medicine), MEDICATION error prevention, SPASM treatment, MEDICAL marijuana, ANXIETY, AUTISM, CANNABIS (Genus), CELL receptors, PATIENT safety, TERPENES, DRUG approval, CHILDREN, THERAPEUTICS
Abstract

The article examines the evidence relating to the safety and therapeutic benefit of cannabidiol for pediatric patients. Topics mentioned include suggestions on how pediatricians should respond to queries from parents regarding its use, a systematic review of medical cannabinoids in pediatric patients in 2017, and potential psychiatric and neurocognitive adverse effects of recreational cannabis. INSET: CURRENT STATUS OF FDA-APPROVED CANNABIS OR CANNABIS-DERIVED....

Published
2019

5. Clinically Relevant Developments in Psychiatry.

Author

Aftab, Awais

Subjects
*ANESTHETICS, *DEMENTIA prevention, *ENZYME inhibitors, *THERAPEUTIC use of lithium, *MENTAL illness treatment, *SCHIZOPHRENIA risk factors, *COGNITION disorders, *MEDICAL marijuana, *SEROTONIN uptake inhibitors, *PROPRANOLOL, *OBSESSIVE-compulsive disorder, *ANTIPSYCHOTIC agents, *MENTAL depression, *MAGNETOTHERAPY, *BIPOLAR disorder, *MEDICAL technology, *POST-traumatic stress disorder, *POSTPARTUM depression, *PSYCHIATRIC treatment, *THERAPEUTICS, *PREVENTION, DRUG therapy for schizophrenia, PREVENTION of disease progression
Abstract

The article highlights research developments in psychiatry. Topics discussed include polygenic risk score for schizophrenia and response to lithium in bipolar disorder, pre-reactivation propranolol therapy for post-traumatic stress disorder and cannabidiol as a potential treatment for schizophrenia.

Published
2019

6. Cannabis 2021: What Clinicians Need to Know.

Author

Westreich, Laurence M.

Subjects
*DRUG addiction risk factors, *SUBSTANCE abuse risk factors, *MENTAL illness risk factors, *CANNABIS (Genus), *PROFESSIONS, *ATTITUDE (Psychology), *RISK perception, *RISK assessment, *DIETARY supplements, *MEDICAL marijuana, *THERAPEUTICS
Abstract

The article discusses clinicians' need to manage cannabis-related problems on its growing number of users in 2021. Topics covered include such issues as lack of motivation after years of use, acute intoxication with high-potency edible tetrahydrocannabisol (THC) preparations, depression, anxiety and psychosis, and cannabinoid hyperemesis syndrome (CHS), and diagnostic criteria for cannabis use disorder (CUD). Also noted are cannabis-specific psychotherapeutic techniques.

Published
2021

7. 9 things glaucoma patients want to know: Doctors and staff should provide answers to these questions before patients ask.

Author

Smith, Will

Subjects
*GLAUCOMA diagnosis, *GLAUCOMA treatment, *BLINDNESS, *BLOOD pressure, *EYE, *GLAUCOMA, *HOSPITAL medical staff, *OPHTHALMIC drugs, *PATIENT education, *VISION disorders, *MEDICAL marijuana, *PATIENTS' attitudes, *PHYSICIANS' attitudes, *THERAPEUTICS, *SYMPTOMS
Abstract

The article looks at nine significant issues that glaucoma patients should know about the ocular disease. Topics mentioned include a study that looked at patients diagnosed between 1981 and 2000 compared with patients diagnosed between 1965 and 1980 in the same geographic location, the best treatments for glaucoma, and blurred vision or vision loss caused by angle closure glaucoma.

Published
2018

8. Prescribing Substances of Abuse in Psychiatric Care.

Author

Weber, Samuel R.

Subjects
*BENZODIAZEPINES, *MEDICAL marijuana, *COCAINE, *THERAPEUTIC use of narcotics, *THERAPEUTIC use of LSD, *TRANQUILIZING drugs, *DRUGS of abuse, *PSYCHIATRIC treatment, *HISTORY, *THERAPEUTICS
Abstract

The article reviews the history of prescribing substances that can lead to addiction as treatment for mentally ill patients. Topics covered include the psychoanalyst Sigmund Freud's support of cocaine as a mental stimulant, opioids' use for depression treatment prior to antidepressant medications in the 1950s, and barbiturates' long-standing prescription as anxiolytics and hypnotics. Also noted are hallucinogens' use as an adjunctive treatment in psychotherapy.

Published
2018

9. The Therapeutic Cannabis User: 5 Key Issues.

Author

Witt-Doerring, Josef and Kosten, Thomas

Subjects
*COGNITION disorder risk factors, *LEARNING disabilities, *SUBSTANCE abuse diagnosis, *MEDICAL marijuana laws, *DRUG addiction risk factors, *MENTAL illness drug therapy, *CHRONIC bronchitis, *MEDICAL practice, *MENTAL health, *PATIENT compliance, *PATIENT education, *PHYSICIANS, *PREGNANCY complications, *PUBLIC opinion, *SLEEP deprivation, *SLEEP disorders, *SUBSTANCE abuse in pregnancy, *MEDICAL marijuana, *DISEASE complications, *THERAPEUTICS, *DISEASE risk factors, *DISABILITIES, TRAFFIC accident risk factors
Abstract

The article explores the five key issues that clinicians can consider when encountering the therapeutic cannabis user. Topics covered include education of patients regarding risks of cannabis, some of the adverse effects of cannabis, and the legal consequences of using and possessing cannabis in the U.S.

Published
2018

10. CBD oil's effect may wane in managing seizures.

Author

ZIMLICH, RACHAEL

Subjects
SPASMS, SEIZURES (Medicine), DRUG tolerance, DISEASE management, VEGETABLE oils, MEDICAL marijuana, TREATMENT effectiveness, DRUG administration, DRUG dosage, THERAPEUTICS, PREVENTION
Abstract

The article reports that patients may develop a tolerance to cannabidiol (CBD) oil over time, resulting in a loss of efficacy for seizure control, according to a study at the American Epilepsy Society Annual Meeting. Topics mentioned include U.S. Food and Drug Administration's approval of a CBD oral solution for children with Lennox-Gastaut and Dravet syndromes, definition of tolerance by the research team, and the team's attempt to increase CBD dosing in patients who developed a tolerance.

Published
2019

11. Cannabinoids as future treatment for epilepsy.

Author

FONG, SUSAN L. and KOSSOFF, ERIC H.

Subjects
DRUG therapy for convulsions, MEDICAL marijuana, NEUROTRANSMITTERS, DRUG therapy, EPILEPSY, SPASMS, DRUG approval, TREATMENT effectiveness, CHILDREN, THERAPEUTICS
Abstract

The authors convey their concerns about cannabinoids as future treatment for epilepsy. The authors said scientific proof that supports the efficacy and safety of adjuvant cannabidiol (CBD) use for specific pediatric seizures is accumulating. It is said that epilepsy affects one of 23 persons of the general population. Public interest was said to be fueled by anecdotal reports of children with treatment-refractory epilepsy who had response with CBD use.

Published
2018

12. SCHIZOPHRENIA: PART 1 Convergence of Thought?

Author

Buckley, Peter F.

Subjects
*CLOZAPINE, *SCHIZOPHRENIA risk factors, *SCHIZOPHRENIA treatment, *OLANZAPINE, *MEDICAL marijuana, *ALCOHOLISM, *AUTISM, *MENTAL depression, *DRUG interactions, *BIPOLAR disorder, *DISEASE remission, *THERAPEUTICS
Abstract

The article discusses development in the understanding of schizophrenia. Topics discussed include results from studies which suggest that the neurobiology of schizophrenia converges more with other psychiatric conditions than might otherwise be considered and the legalization of cannabis use and the use of cannabidiol oil in medicine.

Published
2019

13. Medical marijuana for children with cancer: Pediatricians have had concerns about the known risks of marijuana use in children. What's next for kids with cancer?

Author

NIERENGARTEN, MARY BETH

Subjects
MEDICAL marijuana laws, NURSE practitioners, PEDIATRICIANS, PHYSICIANS, MEDICAL marijuana, TUMORS in children, THERAPEUTICS, TUMOR risk factors
Abstract

The article discusses a survey of pediatric oncology providers about their perspectives regarding the use of legal medical marijuana in children with cancer. Topics covered include the difference between providers who are legally eligible to certify (ETC) for medical marijuana, and those who are not eligible (n-ETC), a willingness among most pediatric oncology providers to consider medical marijuana use, and the absence of scientifically rigorous evidence on the benefits of medical marijuana.

Published
2018

14. MARIJUANA, OPIOID USE MORE COMMON IN PATIENTS WITH CANCER.

Subjects
*THERAPEUTIC use of narcotics, *ANALGESICS, *CANCER patients, *TUMORS, *MEDICAL marijuana, *THERAPEUTICS
Abstract

The article discusses a study published in the journal "CANCER" on April 22, 2019 which found that many people with cancer use marijuana and rates of use in the U.S. have increased over time.

Published
2019

15. Medical Marijuana for Pain: What the Evidence Shows.

Author

King, Steven A.

Subjects
*CANCER chemotherapy, *CHRONIC pain, *MEDICAL marijuana, *TREATMENT effectiveness, *THERAPEUTICS
Abstract

The article looks at the evidence on the use of medical marijuana for pain management. It reviews clinical trials focused on the effectiveness of cannabinoids for chronic pain, the most common form of pain and the efficacy of cannabinoids for neuropathic pain compared to placebo. Issues regarding the validity of cannabinoids for chronic pain management are discussed such as the improvement in the level of pain and the link of cannabinoids with increased severity of adverse effects.

Published
2015

16. Glaucoma treatment alternatives: Thinking outside the box: Treatment options may expand beyond surgery, medication, and lasers.

Author

Charters, Lynda

Subjects
*GLAUCOMA treatment, *ACUPUNCTURE, *DIETARY supplements, *GINKGO, *INTRAOCULAR pressure, *MEDITATION, *MEDICAL marijuana, *MEMANTINE, *THERAPEUTICS
Abstract

The article looks at some glaucoma treatment alternatives, which may expand beyond surgery, medication, and lasers. They include marijuana, ginkgo, and memantine. Also mentioned are acupuncture, meditation, perfusion pressure, and other supplements such as black currant, Mirtogenol tablets, and palmitoylethanolamide.

Published
2020

17. Study finds dispensaries recommend marijuana for glaucoma treatment: Employees advocate drug's benefits, contradicting American Glaucoma Society position.

Author

Charters, Lynda

Subjects
*GLAUCOMA, *PRODUCT safety, *MEDICAL marijuana, *CONSUMER activism, *THERAPEUTICS
Abstract

The article discusses a study to examine recommendations that employees of medical marijuana dispensaries are giving patients who may consider marijuana as an option to treat their glaucoma. Highlights include the availability of marijuana products recommended for glaucoma treatment, percentage of respondents who claimed that the marijuana products were safe, and the importance of patient education during clinical encounters about marijuana use as a glaucoma treatment.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results